Small molecule · developed by Sanofi
SAR448851 is an oral capsule formulation studied in Alzheimer's disease and Alzheimer-type dementia.
Summary written with AI from the sources listed at the end of this page.
Alzheimer's DiseaseDementia, Alzheimer's Type
Updated Nov 1, 2026. Something wrong or missing? Report it on the SNY page.
See SNY's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
SNY catalysts and pipeline →